During the treatment of edema in nephrotic patients by the infusion of dextran, Mollison and Rennie (1) noted falls in serum cholesterol concentration which they believed were due to dilution but which persisted after hematocrits had returned to pretreatment levels, and which by calculation from their data were greater than could be accounted for by hemodilution alone. Subsequently Soothill and Kark (2) and Baxter, Goodman and Havel (3) demonstrated that the intravenous infusion of human albumin into nephrotic patients resulted in a significant lowering of serum lipid concentrations. In their studies on nephrotic rats Rosenman and Friedman (4) demonstrated that the infusion of bovine albumin into these animals lowered serum lipid concentrations. Heymann, Nash, Gilkey and Lewis (5) treated nephrotic rats with dextran and noted significant reductions in the serum concentrations of total lipid and cholesterol. They recognized that these reductions resulted from more than hemodilution, but offered no explanation for this effect. This study was undertaken to investigate more extensively the effects of the administration of dextran on the hyperlipidemia of experimental nephrosis in rats, and to see whether these effects were shared by osmotically active macromolecular substances other than dextran and albumin.
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METHODS
Female rats of the Osborne-Mendel strain, weighing approximately 200 g, were made nephrotic by the intravenous injection of an aliquot of pooled antirat-kidney rabbit serum prepared as previously reported from this laboratory (6) . Eleven days after injection of the antiserum a control blood sample of approximately 1.2 ml volume was obtained by heart puncture after a 6 hour fast. On Days 12, 13 and 14 after injection of the antiserum the rats received, twice daily, intraperitoneal injections of dextran, polyvinylpyrrolidone (PVP), bovine y-globulin, bovine albumin or salt in solutions as described below. On Day 15 following antiserum injection, approximately 20 hours after the last intraperitoneal injection and again after a 6 hour fast, the final blood sample was obtained by aspiration from the exposed abdominal aorta. Both heart puncture and aortic aspiration were done under ether anesthesia. Both blood samples were obtained through clean, dry needles into heparinized syringes. Normal control animals were handled as were the nephrotic rats except for the initial injection of antiserum. The animals were housed in metabolic cages with free access to water and Purina pellet diet, save for the presampling fasting periods when pellets were withheld. Twenty-four-hour urine collections were made from Days 11 through 15 after the injection of the antiserum and were used for the determination of urinary protein content.
Hematocrits were determined in duplicate on each blood sample by the capillary microhematocrit method immediately after each sample was obtained. Because or external bleeding as a result of the injections; these were not included in the study. Plasma was separated from the blood samples by centrifugation and stored at 5°C in stoppered containers for 1 to 4 days before lipid extraction and the various other determinations described below. Before aliquots were taken for analysis, the plasma samples were brought to 370 C and mixed carefully by inversion. Aliquots were extracted with chloroform-methanol by the method of Havel (7) . Aliquots of the extracted lipids were used for the determination of total lipids by the method of Bragdon (8) , total cholesterol by the method of Zak and co-workers (9) , and phospholipids by a modification of the method of Stewart and Hendry (10), using a factor of 25 for the conversion of lipid phosphorus to phospholipid. Only those nephrotic rats with initial total lipid concentrations of 500 mg per 100 ml or greater (approximately twice the mean normal value in this laboratory) were used in the study. All of the methods were standardized for microdeterminations. Plasma albumin concentrations were determined by a modification of the dye interaction method of Rutstein, Ingenito and Reynolds (11) . Determinations of dextran (12) and PVP (13) were performed on the appropriate samples. Total plasma protein concentrations and urinary protein content were determined by modifications of the method of Hiller, Greif and Beckman (14) .
By the method of Bragdon (8) plasma triglyceride concentration may be determined by appropriate calculations from plasma total lipid, phospholipid, and total and free cholesterol concentrations. Because of the small volume of plasma available, free cholesterol determinations were not performed on the experimental animals. In separate groups of normal and nephrotic rats, however, free and total cholesterol concentrations were determined by a modification of the Schoenheimer-Sperry method (15) . Free cholesterol to total cholesterol ratios of the nephrotic and normal groups were, respectively, 0.28 (SD 0.01) and 0.32 (SD 0.01). By use of these ratios the plasma concentration of free cholesterol was approximated in each animal from the total cholesterol value, and triglyceride concentrations were then calculated. It is recognized that the free cholesterol to total cholesterol ratio may have changed following treatment with these macromolecular substances, but a significant change in this ratio will introduce only a small error into the calculated triglyceride concentration.
Both extraction procedures and chemical determinations were checked for reliability in the presence of the various macromolecular substances used in this study by in vitro addition and duplicate determination. No interference was demonstrated except in the determination of total lipids by the dichromate-reduction method of Bragdon in the presence of PVP. Various extraction methods were tried in an effort to remove PVP from the lipid phase, all of which were unsuccessful owing to the solubility of that compound in both polar and nonpolar solvents. Hence, for the animals treated with PVP, total lipid concentrations were derived from determinations of plasma carboxylic acid ester content done by a modification of the method of Rapport and Alonzo, (16 ( 19) was not observed during these experiments. Most of the animals showed no gross change in food intake and appeared active and healthy throughout the experiment. A number (representing less than one-fourth of the experimental animals) which received the largest volumes by injection appeared lethargic and had roughened fur and diminished food intake. Body weights increased slightly over the 3-day injection period. At the time of the final bleeding the abdominal cavities were inspected. In no animal was there evidence of intraperitoneal infection, and the peritoneal surfaces remained smooth and glistening. As mentioned, a few animals had evidence of intraperitoneal, retroperitoneal or gastrointestinal bleeding consequent to trauma at the time of an injection; such animals were not considered in the following data. Except for the small percentage of animals that received the largest volumes by intraperitoneal injection, absorption of the administered solutions was grossly complete at the time of the final bleeding. Average 24-hour urine volumes of the various groups increased 1.1 to 1.5 times the control volume.
Effects of the administered substances. As can be seen from Table I the intraperitoneal administration of dextran and PVP to nephrotic rats resulted in mean plasma concentrations of these macromolecules of between 1 and 2 g per cent. It is true, of course, that rapid clearance of the smaller molecules by the nephrotic kidneys resulted in a circulating macromolecular population with a higher average molecular weight than that administered. In those animals receiving y-globulin there were significant increases in total plasma 
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PVP, however, there was a significant fall in this ratio.
From Table V it is evident that nephrotic animals that received dextran, PVP and .y-globulin had a slight increase in their mean corrected plasma albumin concentration during the experimental period, which in no instance was greater than 0.3 g per cent and which was not statistically significant in the dextran group. This slight rise was coupled with a decrease of less than 2 mg per hour in the mean proteinuria of those nephrotic rats receiving dextran and PVP. It should be noted that this increase in serum albumin concentration and decrease in proteinuria represent mean figures, and a number of rats (11 of 28 treated with dextran, 5 of 14 treated with PVP, and 4 of 12 treated with y-globulin) showed no change, or the opposite change, in plasma albumin concentration concomitant with decreases in their hyperlipidemia. The administration of y-globulin to nephrotic rats caused marked increases in their proteinuria, but essentially none of the y-globulin administered to normal rats appeared in their urine during the treatment period. Though not statistically significant in these groups, it is of interest that the mean posttreatment albumin concentrations of all three groups of normal animals were higher than their 504 mean control values. This may represent correction for plasma volume change.
In general, the higher the plasma concen of the various macromolecular substance greater was the decrease in plasma lipid c tration. This relationship was noted fol administration of dextran, PVP, y-globul albumin, although there was considerable tion in the magnitude of the response of di animals to comparable plasma concentrati these macromolecules. when plasma obtained following the administration of heparin to normal rats is incubated with the coconut oil suspension, the initial phase of clearing is followed by a phase of increasing turbidity, as previously described by French, Robinson and Florey (20) . Fortification of the clearing system with albumin enhances clearing and inhibits the return of turbidity, presumably owing to binding of the liberated fatty acids by albumin (21) .
As is shown in Figure 1 we (22) . There was no gross impairment of hepatic lipoprotein synthesis in these rats compared with untreated nephrotic controls, although minor differences cannot be excluded from the data obtained (23) .
In the experiments presented here we could find no evidence that acute or chronic administration of dextran, PVP or y-globulin resulted in the release of lipoprotein lipase in the intact normal or nephrotic rat. This is of interest in that a number of anionic polysaccharides and polyelectrolytes, including heparin and dextran sulfate, do have this capability (24) (25) (26) (27) , and there is little doubt from the work of Opdyke and coworkers (28), Basu and Stewart (29) , and Cohen and Tudhope (30) that chronic administration of substances which release lipoprotein lipase will significantly affect all of the fractions of blood lipids. Our inability to demonstrate lipoprotein lipase release by the compounds used in this study is in agreement with the observations of Stewart (31) who could demonstrate no effect of dextran comparable with that of heparin and dextran sulfate on increasing the electrophoretic mobility of lipoproteins, an effect ascribed by Gordon (32) There are two possible mechanisms on which the present data give no information, but which would seem unlikely in the light of existing data. Both dextran and PVP are rapidly phagocytized by the reticuloendothelial system where they are stored for relatively long periods of time (33) (34) (35) . The majority of existing evidence, however, indicates that serum cholesterol levels are raised rather than lowered by "blockade" of the reticuloendothelial system in rats and other animals (36) (37) (38) . That (41) , however, seem to indicate that even after prolonged periods (7 to 10 days) of limited food intake, or a day of absolute fasting, reductions in the plasma lipids of nephrotic rats are significantly less than those shown in these data. 506 DEXTRAN, PVP, GAMMA GLOBULIN AND NEPHROTIC LIPEMIA Although dextran, PVP, -y-globulin and albumin are of varying chemical structures, they share the ability to exert osmotic pressure in membrane systems. It is appealing to conclude, if only by exclusion, that this trait may cause at least a part of their lipid-reducing effects in nephrotic rats. The observations that similar patterns of lipid reduction result from the administration of these various substances, and that the magnitude of this reduction is in general directly proportional to the plasma concentration -of the administered substance, are consistent with such a hypothesis. There are, of course, other conceivable mechanisms than those mentioned here, and as Baxter, Goodman and Havel (42) have pointed out, multiple factors undoubtedly influence nephrotic hyperlipidemia. Final elucidation of these various factors, as well as assessment of their relative importance, awaits further investigation. SUMMARY 1. The administration of dextran, polyvinylpyrrolidone, bovine y-globulin, and bovine albumin to nephrotic rats in doses sufficient to increase their plasma volume caused significant reductions in their plasma lipid concentrations.
2. Plasma triglyceride concentration decreased more than total cholesterol or phospholipid concentration during treatment with these substances.
3. Administration of these macromolecules to normal rats caused no significant fall in plasma lipid concentration, except in the case of polyvinylpyrrolidone which caused a decrease in total cholesterol and phospholipids. These reductions were proportionally less in normal rats than in nephrotic rats receiving polyvinylpyrrolidone.
4. In general, the magnitude of reduction of the plasma lipid concentrations was directly related to the plasma concentration of the macromolecular substance.
5. There was no significant change in the nephrotic state of the rats, as judged by plasma albumin concentration or proteinuria, adequate to explain the lipid changes.
6. There was no demonstrable evidence that any of these compounds released lipoprotein lipase, or enhanced clearing of plasma lipids by acting as acceptors for free fatty acids.
7. Some mechanisms for this lipid-lowering effect are discussed. The possibility that the osmotic activity of these macromolecular substances is causally related to the falls in lipid concentration is mentioned.
